Ever heard your kin say ‘diabetes runs in the family’. A lesser-known and understood fact about diabetes is that there are four types of diabetes. We know of the three prominent ones — type 1, type 2 and gestational — but the fourth, ‘Monogenic Diabetes’ is what accounts for a small number of people living with type 2 diabetes, but its impact is a significant one.
One of the common misconceptions is using a blanket treatment mechanism for type 2 diabetes, not taking into account the possibility of a monogenic form of diabetes. In India, its prevalence currently accounts for about 2-5 per cent of type 2 diabetes patients who are less than 35 years of age. In the European population, its prevalence is 100 in every million and it affects 1–5 per cent of diabetic people in the USA and other industrialised countries.
A monogenic form of diabetes is caused due to a single gene mutation. The most notable are Neonatal Diabetes Mellitus (NDM) and Maturity-Onset Diabetes of the Young (MODY). While NDM occurs in newborns and infants, MODY occurs in children and adolescents and both are often misdiagnosed with type 1 or type 2 diabetes. Such forms of diabetes can only be diagnosed with genetic testing appropriately that can also accurately determine the base of treatment.
“MODY is a form of diabetes which is very rare. It runs in families and is caused by a single gene mutation but can occur in 14 different forms — each with its own unique clinical characteristics. The signs and symptoms of MODY are like those of type 1 or 2 diabetes like high blood sugar levels, feeling thirsty, frequent urination, weight loss, etc. People with a family history of diabetes, and children or young people with diabetes or hyperglycaemia should opt for genetic testing, basis which MODY can be detected,” Dr Srinivasan Vedantam, Associate director, Lab operations, MedGenome Labs.
The foremost significance of diagnosing monogenic forms of diabetes like MODY is that unless a correct diagnosis is made, patients can be suspected to have type 1 diabetes and advised to have unnecessary lifelong insulin injections.
Here are some of the key points:
* MODY is an autosomal dominant form of diabetes typically occurring before 25 years of age and caused by primary insulin secretion defects.
* Despite its low prevalence, MODY is not a single entity but represents genetic, metabolic, and clinical variations. In some cases, mutations in this gene may confer susceptibility to diabetes mellitus type-II.
* Genetic testing is also recommended for the immediate family so that the novel mutation seen in the test is characterised.
* Diabetes is not a disease and can be easily managed provided its root causes are clear and enables the treating doctor to chart out the right course of treatment.
* A patient living on insulin injections may have MODY, which can be managed and treated with a simple and cheap prescription of ‘Sulphonylurea’ tablet which has been used for decades in treating diabetes.
This clearly reflects that right understanding of the disease and awareness about the monogenic form of diabetes can be a dramatic change as far as the treatment and the life of such patients are concerned.
“Genetic testing in diabetes can be a life-changer for patients who depend upon costly insulin treatments. Having witnessed the advantage of genetic tests in decoding healthcare problems and concerns such as cancer, rare diseases, reproductive health or infectious diseases like tuberculosis, Indian is warming up to genetic analysis. But the tool needs a lot of awareness, trust and research to be able to mainstream its impact,” adds Dr Srinivasan.
Awareness about all aspects of every disease especially diabetes, which is the most prevalent lifestyle disease today in the country, is important. A slight treatment modification based upon the actual cause of a disease can significantly improve one’s quality of life.
📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines